Document:

Biodiesel Purchase Agreement

 Exhibit 10.50 
 Confidential Treatment Requested. Confidential portions of this document have been redacted and 
 have been separately filed with the Commission. 
  

							
	 
	 PILOT TRAVEL CENTERS LLC
 BIODIESEL PURCHASE AGREEMENT

“AGREEMENT”

 

	Buyer:	  	     Pilot Travel Centers LLC 

    5508 Lonas Road

    Knoxville, TN 37909
	  	Buyer Contact:	  	Mr. David Dobbins
	Seller:	  	  
 REG Marketing &
Logistics Group, LLC
 416 South Bell Avenue
 Ames, IA 50010
  
	  	Seller Contact:	  	    
 Gary Haer

	    	  	 	  	 	  	 
	    	  	 	  	.	  	 
	Date:	  	 	  	 	  	 
	Product: 	  	      Biodiesel B100 or B99.9 (ASTM D6751
Biodiesel) (“Product” or “Biodiesel”)
	  
 Quantity:

	  	  
 Over the term of the Agreement, approximately *** gallons (the “Contract Quantity”) +/- the Purchasing Variance (as defined below).

	  
 Price:
	  	  

Previous day, nearby month, *** price plus $*** per gallon FOB Buyer’s *** and *** locations for B100 or B99.9. *

 
 *Should the *** be *** for *** and moved to the ***, Seller will
reduce the per gallon price of the B100 or the B99.9 by the per gallon amount of the *** received by Seller. Should the *** be *** for *** as a ***, Seller will reduce the per gallon price of the B99.9 by the amount of the *** on such
gallons.
  
 Regardless of whether the *** is moved to
the *** or remains as a ***, if the *** is enacted after *** with a ***, Buyer and Seller agree to *** the *** of the *** from the *** of the ***, but agree *** receives *** of the *** as of *** of *** and forward.

 

	Terms:	  	 Net *** days receipt of invoice via ACH and per
the “Biodiesel Purchase Terms” (“Terms”) of this Agreement

	 Term of Agreement:

 
	  	
January 1, 2012 through December 31, 2012.

 

	F.O.B.	  	 FOB Various locations as required by Buyer and
as further delineated in the Terms.

	 Mode of

Transportation:
  
     
 Invoice To:
	  	 Tanker
truck
     
 Pilot Travel Centers LLC
 5508 Lonas Road

Knoxville, TN 37909
 Attn: Fuel Payables

 SEE THE ATTACHMENT FOR 

ADDITIONAL “TERMS” WHICH ARE REFERRED TO AND 
 INCORPORATED HEREIN BY REFERENCE 
  

									
	 Seller: REG Marketing & Logistics Group, LLC
	 		 	 Buyer: PILOT TRAVEL CENTERS LLC

					
	 By:
	 	 /s/ Gary Haer
	 		 	 By:
	 	 /s/ David A. Dobbins

					
	 Name:
	 	 Gray Haer
	 		 	 Name:
	 	 David A. Dobbins

					
	 Date:
	 	 December 13, 2011
	 		 	 Date:
	 	 December 13, 2011

 *** Confidential material redacted and filed separately with the Commission.

  

 BIODIESEL PURCHASE TERMS 
 These terms and conditions (“Terms”) apply to any agreement to which they are attached, or in which they are incorporated by reference. The agreement which incorporates the Terms and these Terms
are collectively referred to as the “Agreement”, and the terms “Biodiesel” and/or “Product” refer to those monalkyl esters of long chain fatty acids purchased by Pilot Travel Centers LLC (“Buyer”) under the
Agreement from REG Marketing & Logistics Group, LLC (“Seller”). 
 1. Taxes: In addition to the
per gallon purchase price stated below, Buyer will be liable for, and will pay and/or reimburse Seller for the payment of, any and all taxes, fees, duties, assessments and other charges (“Tax”), whether now existing or hereafter arising,
which are imposed, levied or assessed by any federal, state, tribal or local governmental or regulatory authority with respect to the products sold and delivered to Buyer, the taxable incident of which arises out of or relates to the sale, delivery,
receipt, transfer of title, inspection, removal from storage, measurement, receipt of payment, or other activity, regardless of when imposed, of the products to Buyer, or Buyer’s payment therefor. In the event that Seller is required to pay any
such Tax directly to the appropriate authority, Buyer will promptly upon demand reimburse Seller for such payments. Buyer will furnish Seller with any exemption or resale certificate or direct payment permit to which Buyer may be entitled and will
promptly notify Seller of any change in the validity or scope of the same. Buyer shall not be responsible for any taxes based on income, corporate franchise tax, or license fee of Seller. Buyer shall be responsible for any tax arising from the sale,
transfer, or delivery of the Biodiesel to Buyer under this Agreement. 
 2. Quantity: Buyer shall purchase and
receive from Seller and Seller shall sell and deliver to Buyer an amount equal to the Contract Quantity, as specified on the cover page of this Agreement. A purchasing variance of *** plus or minus shall apply to the Monthly Volumes (as defined
below) as set forth below (“Purchasing Variance”). 
 Buyer will designate quantities required at each Designated
Location (as defined below) on a monthly basis (the “Monthly Volumes”). The initial schedule of Monthly Volumes is attached as Appendix A. Buyer shall purchase and receive from Seller and Seller shall sell and deliver to Buyer on a ratable
basis each month an amount equal to the Monthly Volumes specified for each Designated Location for that month as further specified on Appendix A. A purchasing variance of *** plus or minus shall apply to each of the Monthly Volumes. Buyer may modify
Monthly Volumes required at each Designated Location with thirty (30) days prior notice to Seller for good reason, provided that during the Term of this Agreement, the Buyer purchases and receives a total amount each month equal to the Monthly
Volumes, plus or minus the Purchasing Variance and provided further that any change in the Monthly Volumes greater than *** is mutually agreed. Good reason shall include, but not be limited to, a sale of a Designated Location. Buyer’s desire to
source biodiesel from another party shall not be considered a good reason. 
 Buyer and Seller acknowledge Buyer has bought and
will hold in storage approximately *** gallons of *** biodiesel (“Prebought Biodiesel”), *** gallons purchased from Seller and *** purchased from third parties. Beginning January 1, 2012 the Prebought Biodiesel inventory will begin to
be liquidated to satisfy Buyer’s Monthly Volume needs as set forth on Appendix A. *** gallons of the Prebought Biodiesel purchased from Seller will be liquidated as set forth in the 2011 Biodiesel Purchase Agreement Amendment #3 dated
November 9, 2011. The remaining *** Prebought Biodiesel, which includes the remaining *** gallons of Prebought Biodiesel purchased from Seller under a separate contract, is held in storage by Buyer and will be liquidated as needed to satisfy
the Monthly Volume requirements as set forth on Appendix A during the months of January, February and March. Buyer and Seller anticipate that the Prebought Biodiesel gallons will meet Buyers needs into the beginning of March and Seller and Buyer
agree that the Biodiesel to be purchased under this Agreement shall begin in March when needed to meet Buyer’s Monthly Volume requirements. 

  

 *** Confidential material redacted and filed separately with the Commission.

  

 Notwithstanding any other provision of this Agreement, Buyer and Seller have agreed that
Seller will put into storage an aggregate of *** gallons of the Biodiesel to be purchased under this Agreement during the months of January, February and/or March. At the time of delivery into storage, which shall be at Seller’s election, Buyer
agrees to pre-pay Seller for such Biodiesel even though such Biodiesel will not have been delivered to a Designated Location. Buyer agrees to pre-pay Seller for such gallons by bank ACH wire transfer based on weekly invoices with said wire transfer
to be made to Seller within *** days after receipt of invoice. 
 Notwithstanding any other provision of this Agreement, at any
time after this Agreement is executed or during the Term of this Agreement and any extensions thereof, in the event Buyer closes a Designated Location(s), ceases operation of a Designated Location(s) or transfers its ownership interest, whether fee
or leasehold to a third party, Buyer shall be entitled to transfer the volume associated with said Designated Location(s) to another of Buyers locations, provided that such locations are within *** of Seller’s facilities. 

Upon mutual agreement between Buyer and Seller, the Contract Quantity specified on the cover page of this Agreement can be further
increased or decreased. 
 3. Delivery Terms: All sales shall be F.O.B. Buyer’s locations. It is expressly
understood that all sales are on a *** basis unless the parties mutual agree otherwise. The “F.O.B. Point” stated in these Terms shall, at a minimum, include the following locations (each, a “Designated Location”): 

*** 
 Buyer and
Seller may mutually agree to modify, to add to and/or to delete Designated Locations throughout the term of this Agreement. Buyer’s discretion to modify, to add to and/or to delete Designated Locations is limited to Buyer’s locations
within the states of ***, ***, ***, ***, ***, and *** and within *** of Seller’s facility located at ***, ***, ***, or *** (“Seller’s Facility”), provided that during the Term of this Agreement, the Buyer purchases and receives a
total amount equal to the Contract Quantity, plus or minus ***. 
 Seller, its agents or subcontractors must be properly
licensed, trained, understand and follow Buyer’s policies and procedures regarding fuel delivery, and are familiar with the physical layout, drop sites, underground storage tanks, and ingress and egress routes of the Designated Location(s)
before delivery. Seller, its agents or subcontractors agree to work with Buyer in keeping the unloading area clean. Seller, its agents or subcontractors further agree that in the event of a spill that occurs solely as a result of their negligence,
they assume any and all cleanup liability related thereto. Buyer may, with good reason and with thirty (30) days notice to Seller, request that Seller replace any agent or subcontractor acting on Seller’s behalf. Good reason shall include
safety, environmental and other legitimate operational concerns. 
 Upon first delivery of Biodiesel under this Agreement at
each Designated Location, and unless waived by Buyer, Biodiesel inventory levels at each Designated Location will be managed on a ***, with Biodiesel inventory levels at each Designated Location maintained at a minimum of *** and a maximum of *** of
that Designated Location’s Tank capacity, provided that maintaining the minimum inventory levels at each Designated Location does not require Seller to ship more than the applicable Monthly Volumes, plus or minus the ***. 

If Seller, its agents or subcontractors fail to deliver or make available (up to the maximum quantity allowed to Buyer under this
contract) the volume required by Buyer, by Designated 

  

 *** Confidential material redacted and filed separately with the Commission.

  

 
Location, such that any or all of Buyer’s Designated Locations run out of Biodiesel for any reason other than force majeure (provided that Seller shall not by such provision be required to
ship more than the applicable Monthly Volume for a Designated Location, plus or minus the Purchasing Variance), then Seller shall have breached this Agreement. In addition to such other rights and remedies as may be available to Buyer, Seller shall,
within ten (10) days after delivery of reasonable documentation from Buyer *** the *** to *** an *** to *** on a ***, of *** or *** to *** has *** to ***, if any, ***, ***, or *** directly caused by ***. In addition, the applicable Contract
Quantity and the applicable Monthly Volume shall be reduced by the quantity of *** or *** sourced by the Buyer. 
 To the extent Buyer *** to
***, the *** will be *** by *** the *** the ***, at the ***, of the *** and the *** the *** by the Buyer. To the extent *** to *** will be *** by *** the *** the ***, at the ***, of the *** and the *** of the ***, if any *** the *** of *** by the
Buyer. To the extent *** a *** for *** or *** (in the event of ***, ***, if any), *** shall *** the *** and *** for *** shall be *** by ***. 
 The *** will be calculated as the difference between the ***, to which the Buyer would have been entitled if not for the Seller’s breach, and the actual credits received by the Buyer; provided that,
it shall be the Buyer’s sole responsibility to evidence, with documentation provided by the ***, the extent of such difference and that such difference arose solely as a consequence of Seller’s breach. 

4. Risk of Loss I Title Transfer: Title and risk of loss shall pass to Buyer at the *** transfers into the receiving
Tank(s). Buyer will only be responsible for gallons actually delivered by Seller’s truck. Seller agrees that Buyer may (in order of preference) (a) use electronic monitoring systems to track fuel inventory levels and/or (b) cause
Seller’s delivery trucks to be weighed on calibrated scales at Buyer’s Designated Locations before and after the Product has been delivered at Buyer’s Designated Locations. Quantities of Product delivered will be deemed to be the
amount listed on the Bill of Lading generated by Seller’s Facility or any other Biodiesel facility or terminal; provided however, that in the event that either (a) the gallons shown on the electronic monitoring system installed by Buyer or
(b) the gallons calculated from the before/after weight of the truck, is not within *** gallons of the gallons printed on Seller’s Bill of Lading, only those gallons calculated to have been delivered by (a) the electronic monitoring
system or (b) the before/after weigh in of the delivery truck shall be deemed to have been delivered to and purchased by Buyer and Seller shall be deemed to have failed to sell and deliver any differences. Any scales and/or electronic
monitoring systems used by Buyer will be, in all cases, certified by the relevant government agency, and such certification shall be current at the time of measurement. Seller has the right to inspect and verify the accuracy of the electronic
monitoring systems or weigh scales. 
 Should Buyer desire to utilize its own transportation assets to take delivery ***, Buyer
and Seller agree to use good faith efforts to accommodate Buyer. Should Buyer take delivery FOB Seller’s Facilities: 
 a)
Buyer and Seller agree to renegotiate the pricing to reflect Seller’s changed cost of selling on an *** versus a delivered basis. 
 b) The title and risk of loss shall pass to Buyer as Biodiesel enters the receiving equipment of Buyer’s truck. In the event Buyer elects to take deliveries ***: 

c) Buyer is responsible to present suitable trucks for loading and shall comply with all safety and operating procedures applicable to
and at Seller’s Facility, and the Quality and Quantity of the goods will be considered final at loading, 
 d) Buyer may
*** with *** provided by Buyer at Seller’s facilities. Seller shall retain title to any vapors or condensate recovered during delivery, 
 e) Buyer and Seller will need to agree in advance on a schedule for pickup, or other suitable arrangement. 

  

 *** Confidential material redacted and filed separately with the Commission.

  

 5.*** Changes:  
 Notwithstanding anything else to the contrary contained herein, in the event that any *** or *** or *** that *** or *** any *** to the Buyer for the Designated Location(s), Buyer at its sole discretion,
may in whole or in part, unilaterally terminate this Agreement for the affected Designated Location(s) (each a “Terminated Location”). Prior to unilaterally terminating this Agreement for the affected Designated Location(s) pursuant to the
terms of this paragraph, Buyer and Seller shall meet and discuss alternatives to termination. In the event that Buyer and Seller are not able to agree upon an alternative to termination, all of the parties rights, duties and obligations under this
Agreement related to such Terminated Location(s) shall terminate and be of no further force and effect. Buyer may only exercise this right within thirty (30) days of the effective date of the elimination and/or reduction in the credit.

 Due to the *** of the *** of the ***, both parties recognize and agree that the future environment over the term of this contract may not
reflect the environment as of this date. Therefore, should any *** or *** in a manner that *** or *** (in each party’s sole judgment), Buyer and Seller agree to a good faith effort to renegotiate the terms and conditions of this Agreement to
account for such change. Should that renegotiation be unsuccessful, then the disadvantaged party may, at its sole discretion, unilaterally terminate this Agreement for the affected Designated Location(s). In the event a disadvantaged party makes
such an election, all of the parties rights, duties and obligations under this Agreement related to such Terminated Location(s) shall terminate and be of no further force and effect ten (10) days after such party provides written notice to the
other party that it does not believe in good faith that efforts to renegotiate the Agreement will be successful. 
 In the event that any ***,
or ***, or specifically related to the *** of *** for the ***, Buyer and Seller agree to a good faith effort to renegotiate the terms and conditions of this Agreement to account for such change. Should that renegotiation be unsuccessful, then Buyer
at its sole discretion, may in whole or in part, unilaterally terminate this Agreement for the affected Designated Location(s) on sixty (60) days prior written notice. In the event Buyer makes such an election, all of the parties’ rights,
duties and obligations under this Agreement related to such Terminated Location(s) shall terminate and be of no further force and effect at the later of the effective date of such taxes or the end of said sixty (60) day notice period.

 In the event that any *** or *** or *** any *** or *** that *** or *** the *** of ***, and such *** results in Buyer having to *** already
*** with *** for the ***, Buyer may reduce the Contract Quantity by an amount equal to the Buyer’s diesel consumption at the *** times the *** specified by the *** or Buyer and Seller agree to a good faith effort to renegotiate the terms and
conditions of this Agreement to account for such change. Should that renegotiation be unsuccessful, then Buyer at its sole discretion, may in whole or in part, unilaterally terminate this Agreement for the affected *** on sixty (60) days prior
written notice. In the event Buyer makes such an election, all of the parties rights, duties and obligations under this Agreement related to such Terminated Location(s) shall terminate and be of no further force and effect at the later of the
effective date of the Mandate or the end of said sixty (60) day notice period. If such *** the *** of *** that can be ***, *** may reduce the Contract Quantity to *** with the ***. Such reduction(s) in the Contract Quantity will take effect at
the later of the effective date of *** days from Seller’s receipt of Buyer’s written notice. 
 In the event that any *** or *** or
*** any *** or *** that *** the ***, the *** or *** of *** or ***, or the *** uses for *** into *** for the Designated Location(s), Buyer and Seller agree to a good faith effort to renegotiate the terms and conditions of this Agreement to account
for such change. Should that renegotiation be unsuccessful, then Buyer at its sole discretion, may in whole or in part, unilaterally terminate this Agreement for the affected *** on sixty (60) days prior

  

 *** Confidential material redacted and filed separately with the Commission.

  

 
written notice and this Agreement. In the event Buyer makes such an election all of the parties rights, duties and obligations under this Agreement related to such Terminated Location(s) shall
terminate and be of no further force and effect at the later of the effective date of *** or the end of said sixty (60) day notice period. 
 6. Measurement: Quantities delivered to Buyer’s Designated Facilities shall be determined in accordance with Section 4 of this Agreement and the requirements of this Section 6. All
volumes for delivery shall be temperature-adjusted to 60°F using built-in temperature compensators or ASTM tables. Either party may require that Biodiesel quantity be determined by a jointly selected, licensed petroleum inspector, whose findings
shall be conclusive. Customary inspection costs shall be shared equally, but additional services shall be paid for by the party requesting them. The term “gallon” means a U.S. gallon of 231 cubic inches. All measurements and/or tests shall
be made in accordance with the latest standards or guidelines published by ASTM. Objections to measurements, including claims for shortage, for quantities delivered from Seller’s facility must be made to Seller within Sixty (60) calendar
days from the date of delivery. 
 7. Price: Daily prices will be applicable from *** determined from the Product Bill of
Lading as Product is loaded from the Seller’s Facility or any other Biodiesel facility or terminal. 
 The daily price will
be: 
 Previous day, nearby month, *** plus $*** per gallon FOB Buyer’s *** and *** locations for B100 or B99.9. *

 *Should the *** be *** for *** and *** to the ***, Seller will reduce the per gallon price of the B100 or the B99.9 by the ***
of the *** received by Seller. Should the *** be *** for *** as a ***, Seller will reduce the per gallon price of the B99.9 by the amount of the *** on such gallons. 
 Regardless of whether the *** is moved to the *** or remains as a ***, if the *** is *** after *** with a ***, Buyer and Seller agree to *** the *** of the *** from the *** of the ***, but agree ***
receives *** of the *** as of *** of *** and ***. 
 The last reported *** price will be used for weekends, holidays, or other
such times that *** does not publish a value. 
 Due to the uncertain status of the liquidity of the *** over the *** of ***,
both parties acknowledge that an alternate pricing index may be needed. If either party determines in good faith that the *** no longer provides liquidity, it shall so notify the other party and Buyer and Seller agree to convert the price in this
Agreement contract effective upon a mutually determined date from the *** to ***. Upon the effective date of this agreed upon change, the basis adjustment shall change from plus $*** to $*** plus or minus *** difference between the *** during ***
over the time remaining in the contract. 
 Should *** no longer publish the *** or should the market for fuel traded on this
index become illiquid, the parties shall agree to a new index and basis adjustment. 
 8. Payment Terms: 

(a) Buyer agrees to pay Seller by bank ACH wire transfer based on weekly invoices with said wire transfer to be made to Seller within ***
days after receipt of invoice. Buyer shall pay for Net gallons delivered as determined in accordance with Sections 4 and 6 hereof. Buyer shall pay 

  

 *** Confidential material redacted and filed separately with the Commission.

  

 
Seller for delivered product(s) in U.S. dollars without any adjustments, discounts, or setoffs, on or before the due date. All past due payments hereunder shall bear interest from the date due
until the date paid at the rate of *** per month or at the maximum rate authorized by law, whichever is less. Accounts that are past due will be ineligible for applicable allowance, deductions, or discounts, if any. In addition to all other rights
and remedies, Seller shall have the right to suspend, cancel or terminate this Agreement if Buyer does not pay all amounts due to Seller in accordance with the terms of this Agreement. 

(b) In addition to all other rights and remedies, in the event of either party’s default respecting any provision of this Agreement,
the non-defaulting party may offset any damages arising therefrom, including, without limitation, withholding payment, delivery or acceptance of product, material or services, relating to any and all agreements or transactions with the defaulting
party. 
 9. Compliance With Laws: Each of Seller and Buyer will make commercially reasonable efforts to ensure that it
and its employees, contractors, carriers, and agents shall comply with all laws, regulations, and standards applicable to the manufacture, storage, sale, transportation, and disposition of Biodiesel. 

10. Safety and Health: Seller is required to furnish Buyer with a complete Material Safety Data Sheet and other information about
the safety and health aspects of Biodiesel prior to the first delivery and shall provide current and updated Material Safety Data Sheets to Buyer during the term of this Agreement. 

11. Warranty of Title: Seller warrants that it has good title to the Biodiesel sold and delivered hereunder, free of all liens,
charges, encumbrances, pledges or security interests. Seller warrants the Biodiesel is free of any claims of infringement of any patent, copyright or misappropriation of any confidential information or trade secret of other parties. THIS WARRANTY
AND THE WARRANTY IN SECTION 12 ARE THE SOLE WARRANTIES MADE BY SELLER AND ARE IN LIEU OF ALL OTHER EXPRESS OR IMPLIED WARRANTIES. 
 12. Warranty of Quality: Seller represents and warrants that all Biodiesel supplied to the Buyer’s point of title transfer complies with the most current version of ASTM D-6751 Standard
Specification for Fatty Acid Methyl Ester (FAME) B100 for use in compression ignition (diesel) engines (excluding the Appendixes), or in the case of B99.9, complied when it was B100 immediately prior to blending to B99.9. Seller further represents
and warrants that the Biodiesel sold and delivered hereunder complies both with Sections 6426(c), 6427(e) and 40 A of the Internal Revenue Code and the most current quality assurance standard observed by the National Biodiesel Board or its
successor, or in the case of B99.9, complied when it was B100 immediately prior to blending to B99.9. Seller represents and warrants that the biodiesel is merchantable and fit for blending into petroleum diesel for on-road consumption. 

Seller will, at Buyer’s option and at Seller’s cost (including, but not limited to, laboratory costs, shipping, and handling),
submit sufficient samples of Biodiesel to an independent third party laboratory of Buyer’s choosing for quality assurance testing that the Biodiesel meets all specifications described in the Warranty of Quality. 

Seller will, at Buyer’s option and at Seller’s cost (including expense of return and re-delivery), remedy the defect in,
replace, or refund the purchase price of, any Biodiesel that fails to meet this warranty. 

  

 *** Confidential material redacted and filed separately with the Commission.

  

 Seller additionally represents and warrants that any Biodiesel sold to Buyer during the
months of ***, ***, *** will have a maximum cloud point of ***; and during the months of ***, *** and *** a maximum cloud point of ***. If Buyer, after handling the Biodiesel in conformance with industry practices, experiences any problems with
Biodiesel blending resulting from cold weather situations, both parties agree to work together to resolve the issue. With written agreement, Buyer and Seller may agree to waive this cloud point requirement if weather conditions and/or other factors
allow. 
 Seller will be BQ9000 compliant, or diligently pursuing compliance, during the term of this contract. 

13. Biodiesel Certification: Seller shall provide Buyer a Biodiesel Certificate of Analysis (“CoA”) for each shipment
setting forth at least the following data: Biodiesel source; lab ID; date of lab receipt, date of analysis; test results for the requirement that the Biodiesel meet the most recent ASTM D-6751 Standard Specification for Fatty Acid Methyl Ester
(FAME) B100 for use in compression ignition (diesel) engines. 
 Seller shall provide Buyer at the ***, documentation for each
load uniquely referencing the CoA applicable to that load and stating: “Fatty Acid Methyl Ester (FAME) B100 containing a minimum 96.5% methyl ester by weight and meeting all applicable ASTM specifications” or “B99.9, made from Fatty
Acid Methyl Ester (FAME) B100 containing a minimum 96.5% methyl ester by weight and meeting all applicable ASTM specifications and 0.1% ULSD. 
 In accordance with EPA’s RFS regulations at *** shall *** to at *** and ***, but *** than *** to *** for each *** of *** by *** at the *** of the *** is *** to ***. All such *** shall be for the ***
in which *** was *** to ***, shall be *** with a *** of ***, and shall be *** via a *** that is *** with ***. 
 Seller represents and warrants
that: 
  

	 	a)	The *** were *** and *** into the *** between *** and *** under the *** of the *** and Seller has the right to *** pursuant to the ***; and 

 

	 	b)	Seller has *** and *** to the *** and *** are *** and *** of any *** or *** Seller, and 

 

	 	c)	The *** have not been previously *** for *** by an *** or ***; and 

  

	 	d)	Seller has complied with all applicable requirements of *** and *** with regard to the *** and the *** of the ***. 

In the event that Seller breaches any of the warranties contained herein (creating a ***), Seller shall *** (at Seller’s own cost and expense), the
*** with a *** of *** and *** within 30 days of *** of the ***. 
 14. Force Majeure: Neither party shall be liable to
the other for any delay or failure in performance to the extent that it is caused by circumstances beyond its reasonable control, or by fire; explosion; flood; earthquake; storm; act of God; sabotage or vandalism; strike or other labor disturbance
(neither Seller nor Buyer shall be required to settle a labor dispute or take an action that might involve it in a labor dispute); interruption of utility services; or compliance with any law, regulation or order (regardless of validity) of any
governmental or military authority (“Force Majeure Event”); provided however, that notwithstanding the forgoing, a failure to make payments accrued prior to a Force Majeure Event when due shall not be excused. *** of *** or *** is not a
Force Majeure Event. In the event of a Seller Force Majeure Event, nothing contained in this Agreement 

  

 *** Confidential material redacted and filed separately with the Commission.

  

 
shall be construed to require Seller to produce or acquire Biodiesel from facilities other than Seller’s Facility. 
 15. Indemnity: Seller shall indemnify, defend and hold harmless Buyer and its employees and agents (“Buyer Indemnitees”) against any loss, claim, liability (actual or alleged), fine, or
expense (including consequential, incidental, lost profits, or punitive damages, and further to include court costs, attorney fees, and litigation expenses)(“Damages”), of any kind (including those based in tort, warranty, or strict
liability), to the extent asserted by a third party against the Buyer Indemnitees and arising out of, or in connection with any failure of Seller to comply with this Agreement, or any act or failure to act by Seller in the handling, storage,
transportation, or sale of Biodiesel purchased under the Agreement. In responding to such third-party claims, if Seller has acknowledged in writing its obligation to indemnify Buyer Indemnitees from any such Damages, Seller may select an attorney
and may enter into any settlement without affecting this obligation. 
 Likewise, Buyer shall indemnify, defend and hold harmless Seller and its
employees and agents (“Seller Indemnitees”) against any Damages, of any kind (including those based in tort, warranty, or strict liability), to the extent asserted by a third party against the Seller Indemnitees and arising out of, or in
connection with any failure of Buyer to comply with this Agreement, or any act or failure to act by Buyer in the handling, storage, transportation, or sale of Biodiesel purchased under the Agreement. In responding to any third-party claims, if Buyer
has acknowledged in writing its obligation to indemnify Seller Indemnitees from any such Damages, Buyer may select an attorney and may enter into any settlement without affecting this obligation. 

16. Limitation of Liability: Subject to the obligations of Section 3, Section 14, and Section 15, neither party
shall be liable to the other for consequential, incidental, lost profits, or punitive damages arising out of any breach of this Agreement or for any other reason. 
 17. Default and Termination: Either party may terminate the Agreement in the event of a material default by the other party that is not cured within thirty (30) days after notice of default is
given. Upon giving of such notice to the defaulting party, the non-defaulting party may defer shipments or receipt of deliveries until default is cured by the defaulting party. The right to terminate is in addition to any other remedy that may be
available. A waiver of a default in one instance does not extend to any subsequent default. Termination of this Agreement shall not relieve Buyer from payment for all Product delivered prior to such termination. In the event of termination of this
Agreement, Buyer shall have no further obligation to take Product pursuant to this Agreement and Seller shall have no further obligation to sell or deliver Product pursuant to this Agreement. Notwithstanding any other provision in this
Section 17 or this Agreement, if a specific damage remedy for a default is provided under this Agreement (including without limitation, Section 3) and such damages are timely paid by the defaulting party, then such payment shall constitute
cure of the default for the purposes of this Section 17 and the non-defaulting party shall not have the right to terminate this Agreement for such default. 
 19. ***: Both parties shall make all necessary reasonable efforts to ensure that the *** is fully available to the *** of the fuel. However, Seller makes no *** regarding whether *** will
ultimately *** the ***. 
 20. Governing Law: The purchase of Biodiesel by Buyer, and the Agreement, shall be governed by
Tennessee law, excluding its conflict of laws provisions and excluding the United Nations Convention on Contracts for the International Sales of Goods. 
 21. Survivorship: Seller’s obligations in Sections 1, 8, 11, 13, 15, 16, and 19 above shall survive termination of the Agreement. Buyer’s obligations in Sections 1, 8, 15, 16 and 19 above

  

 *** Confidential material redacted and filed separately with the Commission.

  

 
shall survive termination of the Agreement. 
 22. Enforceability:
The invalidity or unenforceability of any part of the Agreement shall not affect the validity or enforceability of its remaining provisions. 
 23. Anti-Waiver: The right of either party to require strict performance by the other of any and/or all the obligations imposed upon the other by the Agreement shall not in any way be
affected by any previous waiver, forbearance or course of dealing. 
 24. Merger: The Agreement contains the entire
agreement of the parties with respect to its subject matter. 
 25. Assignment: The Agreement, and any rights or duties
under it may not be assigned or delegated by operation of law or otherwise by Seller or Buyer without the prior written consent of the other, which consent shall not be unreasonably withheld, conditioned or delayed. Notwithstanding the foregoing,
Seller shall be permitted to assign its rights and/or obligations under the Agreement without the prior consent of Buyer (a) to another entity, or to Seller’s affiliate or successor (collectively herein “Assignee”), if such
Assignee expressly assumes all obligations not otherwise remaining with Seller hereunder, and Seller nonetheless remains responsible hereunder, and (b) to any lender as collateral security for any indebtedness of Seller to such lender,
provided, however, that any further assignment by Seller’s lender requires the prior written consent of Buyer, which consent shall not be unreasonably withheld, conditioned or delayed. Any attempted assignment or delegation in violation of this
Section 25 shall be void. 
 26. Notice Requirement: Any claim or notice required by the Agreement to be given shall
be in writing and shall be sent by either (a) certified mail return receipt requested; (b) by a national overnight courier service to the address specified on page one of the Biodiesel Purchase Agreement to which these terms are attached;
or (c) by facsimile to the number specified on page one of the Biodiesel Purchase Agreement to which these terms are attached followed within five business days by a copy delivered by certified mail return receipt requested or by national
overnight courier service. 
 27. Modification: Both parties agree that no proposals, amendments, modifications, purchase
orders, other writings or actions will modify the terms of this Agreement unless they are in writing and are signed by authorized representatives of both parties. 
 28. Buyer’s Quality Initiative: Seller shall use commercially reasonable efforts to ensure that Seller’s employees, contractors, carriers, and agents reasonably cooperate with
Buyer’s reasonable product quality initiatives, including completion of Buyer’s survey questionnaires and granting Buyer permission to conduct reasonable periodic on-site auditing upon reasonable prior notice of the manufacturing, storage,
sampling, testing, inspection, loading, and transportation processes; provided that prior to the event of such on-site auditing Buyer agrees to be bound by such confidentiality provisions as are requested by Seller. 

29.***: Effective as of the date of this Agreement, and through the end of its Term, in the event that *** to an *** in a
*** at a *** to *** than the *** to the *** as provided herein, then *** shall *** the *** to the *** to *** any such ***. The *** of the *** shall be effective as of the date that the *** was *** for the ***, and shall be effective for the *** to
be *** within the *** for which the *** is *** for the ***. 
 An “***,” as that term is used here, is defined as a
*** within the states of *** or ***. 

 *** Confidential material redacted and filed separately with the Commission.

  

 A “***,” as that term is used here, is defined as a *** within the *** of a
*** between the *** and a single *** taken as a whole; involving not less than *** for *** within a ***; for the same *** as those specified in ***, or portions thereof; for delivery within the states of *** or ***; and with *** and *** to those
***. 
 The *** shall be *** on the basis of *** by *** to an *** in a ***, on the *** at which the *** was concluded.

 Should Buyer desire an inspection or audit to determine compliance with provisions of this Section 29, Buyer shall
nonetheless not be entitled to review any information which relates to the confidential information of a third party. With respect to such information the Buyer shall have the right, subject to the terms of this Section 29, to engage an
independent auditor to perform such inspection that is otherwise permitted hereunder (such independent auditor agreeing to sign an appropriate agreement to hold such information confidential). Alternatively, at Buyer’s option, the Buyer may
seek the verification and certification of compliance contemplated above from Seller’s independent auditors. 
 The expense
of any such inspection or audit shall be borne by the Buyer, unless the need for a material correction in the premium to be charged to the Buyer results, in which case the reasonable expense of such inspection or audit shall be borne by the Seller
whose books and records are being audited. 
 30. Miscellaneous: If Buyer designates a third party location for delivery
in accordance with the terms of this Agreement, Seller shall use reasonable commercial efforts to ensure that its transport carriers, contractors, and agents execute and comply with third party’s access, loading/unloading, receipt and/or
delivery procedures. Seller shall use reasonable commercial efforts to ensure that all Seller’s employees, contractors, and agents comply with all reasonable rules and guidelines established by Buyer from time to time, including applicable
safety rules and its Drug, Alcohol, And Firearm Policy which prohibits possession, use, consumption, distribution or sale of drugs, drug paraphernalia, alcohol, firearms, ammunition or other weapons upon Buyer’s premises. 

31. Carbon Credits: *** shall retain title to any and all carbon credits associated with the Biodiesel sold pursuant to this
Agreement. 
 END OF DOCUMENT-NO SIGNATURE REQUIRED. 

 *** Confidential material redacted and filed separately with the Commission.

 Appendix A 
 Biodiesel Gallons 2012 

																																																			
														
	 Store/Location
	  	Jan	  	 	Feb	  	  	 	Mar	  	  	 	Apr	  	  	 	May	  	  	 	Jun	  	  	 	July	  	  	 	Aug	  	  	 	Sep	  	  	 	Oct	  	  	 	Nov	  	  	 	Dec	  	  	 	Total	  
		  	  
	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
														
	 ***
  

 
  
  

 
  
  

 
	  		  				  				  				  				  				  				  				  				  				  				  				  			

  
 13Private Placement Agreement

 Exhibit 10.1 
 PRIVATE PLACEMENT AGREEMENT 
 This PRIVATE PLACEMENT AGREEMENT (this
“Agreement”), dated as of December 23, 2011 by and between Total Gas & Power USA, SAS, a société par actions simplifiée organized under the laws of the Republic of France
(“Investor”), and SunPower Corporation, a Delaware corporation (the “Company”). 

BACKGROUND 
 A. The Company and Investor are executing and delivering this Agreement in reliance upon the exemption from registration afforded by Section 4(2) of the Securities Act of 1933, (the
“Securities Act”), and Rule 506 of Regulation D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities
Act. 
 B. Investor wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement,
the Common Shares (as defined below) together with the preferred stock purchase rights appurtenant thereto issued under the Rights Plan for an aggregate purchase price of $163,680,000.00 (the “Purchase Price”). 

C. Contemporaneously with the Closing under this Agreement, the Company pursuant to the terms of the Stock Purchase Agreement, dated as
of December 23, 2011, by and among SunPower, Tenesol SA, and Investor shall have acquired 100% of the outstanding capital stock of Tenesol SA (the “Tenesol Acquisition”); 

D. Contemporaneously with the execution of this Agreement, the Company and the Investor will execute and deliver a Master Agreement,
dated as of December 23, 2011, by and among the Company, the Investor and Total S.A. (“Total”) which sets forth a series of related transactions and agreements being entered into at the same time and connected to this
Agreement and the Tenesol Acquisition, each as more fully defined therein. 
 NOW, THEREFORE, IN CONSIDERATION of the mutual
covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and Investor agree as follows: 

ARTICLE I 

DEFINITIONS 
 1.1 Definitions. In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings indicated: 

“Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is
controlled by or is under common control with a Person, as such terms are used in and construed under Rule 144 under the Securities Act. 
 “Affiliation Agreement” means that certain Affiliation Agreement dated April 28, 2011, by and among the parties hereto, as the same has and may be amended from time to time.

 “Agreement” has the meaning set forth in the Preamble. 

“Acquisition Agreement” means that certain Acquisition Agreement to be entered into between the Company and Total
Energie Développement SAS, a sister company to the Investor with respect to the purchase by the Company of 100% of the shares of Tenesol, S.A., a French société anonyme. 

“Board” shall mean the Board of Directors of the Company or any authorized committee thereof. 

“Business Day” means any day other than Saturday, Sunday, any day which shall be a federal legal holiday in the
United States or any day on which banking institutions in The State of New York are authorized or required by law or other governmental action to close. 

 “Capital Stock” means Common Stock and Preferred Stock. 

“Capitalization Date” has the meaning set forth in Section 3.1(e)(i). 

“Closing” means the closing of the purchase and sale of the Common Shares pursuant to Section 2.1.

 “Closing Date” has the meaning set forth in Section 2.1. 

“Company” has the meaning set forth in the Preamble. 

“Common Shares” means that number of shares of Common Stock to be issued in the Transaction, determined by
dividing the Purchase Price by the Price Per Share, rounded down to the nearest whole share, together with the preferred stock purchase rights appurtenant thereto issued under the Rights Plan. 

“Common Stock” means the common stock, $0.001 par value, of the Company. 

“Company Securities” has the meaning set forth in Section 3.1(e)(iii). 

“Control” means, as to any Person, the possession of the power to direct or cause the direction of the management
and policies of such Person, whether through the ownership of voting securities, by contract or otherwise. The verb “Control” and the term “Controlled” have the correlative meanings. 

“Convertible Debentures” has the meaning set forth in Section 3.1(e)(i). 

“Convertible Securities” means any stock or securities (other than Options) directly or indirectly convertible
into or exercisable or exchangeable for Common Stock. 
 “DTC” has the meaning set forth in
Section 3.2(k). 
 “Environmental Laws” has the meaning set forth in Section 3.1(k).

 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

“FINRA” has the meaning set forth in Section 3.2(c). 

“Hazardous Materials” has the meaning set forth in Section 3.1(w). 

“Investor” has the meaning set forth in the Preamble. 

“Intellectual Property Rights” has the meaning set forth in Section 3.1(v). 

“Knowledge” or “knowledge” shall mean, with respect to the Company, the actual knowledge
of the executive officers (as defined in Rule 405 under the Securities Act) of the Company after due inquiry. 

“Lien” means any lien, charge, claim, security interest, encumbrance, right of first refusal or other
restriction. 
 “Material Adverse Effect” means any effect that either alone or in combination with any
other effect has, or would reasonably be expected to have, a materially adverse effect in relation to the condition (financial or otherwise), properties, assets, liabilities, business, operations, or results of operations of the Company and its
Subsidiaries, taken as a whole or the ability of the Company and its Subsidiaries to perform their respective obligations hereunder or to consummate the Transaction. 

  
 2 

 “Options” means any outstanding rights, warrants or options to
subscribe for or purchase Common Stock or Convertible Securities. 
 “Person” means any natural person,
general or limited partnership, corporation, limited liability company, joint venture, trust, firm, association or other legal or governmental entity. 
 “Plans” means the 1996 Stock Plan, the Third Amended and Restated 2005 SunPower Corporation Stock Incentive Plan, and the PowerLight Corporation Common Stock Option and Common
Stock Repurchase Plan. 
 “Preferred Stock” means the Preferred Stock, par value $0.001 per share, of
the Company. 
 “Price Per Share” means $8.80, the price to be paid per share for each Common Share.

 “Principal Market” means the Nasdaq Global Select Market. 

“Purchase Price” has the meaning set forth in the preamble. 

“Registrable Securities” means the Common Shares, together with any securities issued or issuable upon any stock
split, dividend or other distribution, recapitalization or similar event with respect to the foregoing. 

“Registration Rights Agreement” means that certain Registration Rights Agreement dated April 28, 2011, by
and among the parties hereto, as the same may be amended from time to time. 
 “Rights Plan” means the
Amended and Restated Rights Agreement, dated November 16, 2011, by and between the Company and Computershare Trust Company, N.A., as Rights Agent, including the form of Certificate of Designation of Series A Junior Participating Preferred Stock
and the forms of Right Certificates, Assignment and Election to Purchase and the Summary of Rights attached thereto as Exhibits A, B and C, respectively. 

“Regulation D” has the meaning set forth in the Preamble. 

“Reporting Period” has the meaning set forth in Section 3.1(j). 

“Restricted Stock” means shares of Common Stock that constitute unvested restricted stock or are otherwise
subject to a right of repurchase or redemption by the Company. 
 “Restricted Stock Unit” means a
bookkeeping entry representing the equivalent of a share of Common Stock. 
 “Rule 144,”
“Rule 415,” and “Rule 424” means Rule 144, Rule 415 and Rule 424, respectively, promulgated by the SEC pursuant to the Securities Act, as such rules may be amended from time to time, or any
similar rule or regulation hereafter adopted by the SEC having substantially the same effect as such rule. 

“SEC” has the meaning set forth in the Preamble. 

“SEC Documents” have the meaning set forth in Section 3.1(j). 

“Securities Act” has the meaning set forth in the Preamble. 

“Shares” means shares of the Company’s Common Stock. 

“Solar SPE” means any directly or indirectly owned special purpose vehicles established to facilitate solar
system sales in the ordinary course of the Company’s utility and power plant or large commercial business lines. 

“Stock Awards” means Options, Restricted Stock and Restricted Stock Units. 

  
 3 

 “Subsidiary” of any Person means any other Person (a) of which
the first Person owns directly or indirectly fifty (50) percent or more of the equity interest in the other Person or (b) of which (or in which) an amount of the voting securities, other voting ownership or voting partnership interests of
which is sufficient to elect at least a majority of its board of directors or other governing body (or, if there are no such voting interests, more than 50 percent of the equity interests of which) is directly or indirectly owned or Controlled by
the first Person, by such Person with one or more of its Subsidiaries or by one or more of such Person’s other Subsidiaries or (c) in which the first Person has the contractual or other power to designate a majority of the board of
directors or other governing body. 
 “Tenesol Acquisition” has the meaning set forth in the Preamble.

 “Trading Day” means (a) a day on which the Common Stock is traded on a Trading Market (other
than the OTC Bulletin Board), or (b) if the Common Stock is not listed or quoted on a Trading Market (other than the OTC Bulletin Board), a day on which the Common Stock is traded in the over-the-counter market, as reported by the OTC Bulletin
Board, or (c) if the Common Stock is not listed or quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported by the Pink Sheets LLC (or any similar organization or agency succeeding to
its functions of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth in (a), (b) and (c) hereof, then Trading Day shall mean a Business Day. 

“Trading Market” means whichever of the New York Stock Exchange, the American Stock Exchange, the NASDAQ Global
Select Market, the NASDAQ Global Market, the NASDAQ Capital Market or OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date in question. 
 “Transactions” means those transactions contemplated by the Transaction Documents. 
 “Transaction Documents” means this Agreement, including the schedules, annexes and exhibits attached hereto, and the Transfer Agent Instructions and each of the other agreements or
instruments entered into or executed by the parties hereto in connection with the transactions contemplated by this Agreement. 

“Transfer Agent” means Computershare Trust Company, N.A., or any successor transfer agent for the Company.

 “Transfer Agent Instructions” means, with respect to the Company, the Company Transfer Agent
Instructions, in substantially the form of Exhibit A, executed by the Company and delivered to and acknowledged in writing by the Transfer Agent. 
 ARTICLE II 
 PURCHASE AND SALE 

2.1 Closing. Subject to the terms and conditions set forth in this Agreement, at the Closing the Company shall issue and
sell to Investor, and Investor shall purchase from the Company, the Common Shares for the Purchase Price. The date and time of the Closing shall be at 1:00 p.m., New York City Time, on January 24, 2012, or such later date as is mutually agreed
upon in writing by the Company and the Investor (the “Closing Date”). The Closing shall take place at the offices of the Company’s counsel. 
 2.2 Closing Deliverables. 
 (a) At the Closing, the Company shall
deliver or cause to be delivered to Investor the following: 
 (i) a copy of the Company’s irrevocable instructions to the
Transfer Agent instructing the Transfer Agent to establish and credit, on an expedited basis, a restricted book entry at such Transfer Agent evidencing the Common Shares in a segregated account established by the Transfer Agent for the
Investor’s benefit and registered in the name of Investor; 

  
 4 

 (ii) duly executed Transfer Agent Instructions acknowledged by the Company’s transfer
agent; 
 (iii) an opinion of Jones Day, counsel for the Company (“Company Counsel”), dated as of the Closing
Date, in substantially the form attached hereto as Exhibit B; 
 (iv) a certificate, executed by the Secretary of the
Company and dated as of the Closing Date, as to (A) the resolutions consistent with Section 3.1(b) as adopted by the Company’s Board of Directors in a form reasonably acceptable to such Investor, (B) the certificate of
incorporation, and (C) the bylaws, each as in effect as of the Closing Date; 
 (v) the Special Committee of the Board of
Directors of the Company shall have received on the date of this Agreement the opinion of Deutsche Bank Securities Inc. as investment bankers that, as of the date of such opinion, and subject to the assumptions made, matters considered and limits of
review set forth therein, the $165,375,000 cash purchase price in the Acquisition Agreement, subject to potential downward adjustments based on closing net working capital and net cash amounts, as described in Section 2.3 of the Acquisition
Agreement, is fair, from a financial point of view, to SunPower; 
 (vi) a written waiver or amendment to the Company’s
Revolving Credit Agreement, dated as of September 27, 2011, among the Company and the Lenders named therein (the “Credit Agreement”) on terms reasonably acceptable to Investor sufficient to ensure no default or event of default
under the credit Agreement is continuing; and 
 (vii) such other documents relating to the transactions contemplated by this
Agreement as Investor or its counsel may reasonably request. 
 (b) At the Closing, Investor shall deliver or cause to be
delivered to the Company the following: 
 (i) The Purchase Price, by wire transfer to an account designated in writing to such
Investor by the Company for such purpose. 
 ARTICLE III 

REPRESENTATIONS AND WARRANTIES 
 3.1 Representations and Warranties of the Company. Except as otherwise disclosed or modified by the disclosure schedule set forth as Exhibit C hereto, Company hereby represents
and warrants to Investor as follows: 
 (a) Organization and Qualification. The Company and each Subsidiary is an entity
duly organized and validly existing, and the Company is in good standing under the laws of the jurisdiction of its incorporation, with the requisite legal authority to own and use its properties and assets and to carry on its business as currently
conducted. Each Subsidiary is in good standing under the laws of the jurisdiction of its incorporation or organization, as applicable, with the requisite legal authority to own and use its properties and assets and to carry on its business as
currently conducted, except where the failure to be so in good standing would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary is in violation of any
of the provisions of its certificate or articles of incorporation, bylaws or other organizational or charter documents, as applicable. The Company and each Subsidiary is duly qualified to do business and is in good standing as a foreign corporation
or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would not,
individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect. 
 (b)
Authorization; Enforcement. The Company has the requisite corporate authority to enter into the Transaction Documents to which it is a party and to consummate the Transactions contemplated by each of the Transaction Documents to which it is a
party and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of each of the Transaction Documents to which it is a party by the Company and the consummation by it of the transactions contemplated hereby and
thereby including, without limitation, the issuance of the Common Shares, have been duly authorized by all necessary corporate action on the part of the Company and no further consent or action is required by the Company, its Board of Directors or
its stockholders. Each of the Transaction Documents to which it is a party has been (or upon delivery will be) duly executed by 

  
 5 

 
the Company and is, or when delivered in accordance with the terms hereof, will constitute, the valid and binding obligation of the Company enforceable against the Company in accordance with its
terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited
by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law. 

(c) No Conflicts; Consents. The execution, delivery and performance of the Transaction Documents to which it is a party by the
Company and the consummation by the Company of the Transactions do not, and will not, (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws or other
organizational or charter documents, as applicable, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any
Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound, or affected, except to the extent that such conflict, default, termination, amendment, acceleration or cancellation right would not, individually or
in the aggregate, have or reasonably be expected to have a Material Adverse Effect, or (iii) result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to
which the Company or any Subsidiary is subject (including, assuming the accuracy of the representations and warranties of Investor set forth in Section 3.2 hereof, federal and state securities laws and regulations and the rules and
regulations of any self-regulatory organization to which the Company or its securities are subject, including all applicable Trading Markets), or by which any property or asset of the Company or any Subsidiary is bound or affected, except to the
extent that such violation would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is required to obtain any consent, authorization or order
of, or make any filing or registration with, any court, governmental agency or any regulatory or self-regulatory agency or any other Person in order for it to execute, deliver or perform any of its obligations at the Closing under or contemplated by
the Transaction Documents, including without limitation the issuance of the Common Shares, in each case in accordance with the terms hereof or thereof, except for the following consents, authorizations, orders, filings and registrations (none of
which is required to be filed or obtained before the Closing): (x) the filing of a Form D with the SEC and any applicable state securities authorities, (y) the filing of a Form 8-K with the SEC announcing the entry into the Transaction
Documents and the issuance of the Common Shares and (z) the shareholder consent to be signed by Investor, the filing of a preliminary and definitive information statement each on Schedule 14C with the SEC, and satisfaction of the requirements
of the Principal Market. The Company and its Subsidiaries are unaware of any facts or circumstances that would reasonably be expected to prevent the Company from obtaining or effecting any of the registration, application or filings pursuant to the
preceding sentence. 
 (d) The Common Shares. The Common Shares are duly authorized and, when issued and paid for in
accordance with this Agreement, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens, except for customary and required restrictions on transfer under U.S. federal and state securities laws and will not be
subject to preemptive or similar rights of stockholders (other than those rights set forth in the Affiliation Agreement). 
 (e)
Capitalization. 
 (i) The authorized capital stock of the Company consists of (A) 367,500,000 shares of Common
Stock and (B) 10,000,000 shares of Preferred Stock. As of the close of business on December 16, 2011 (the “Capitalization Date”): (1) 100,487,482 shares of Common Stock were issued and outstanding, of which
none were unvested and subject to a right of repurchase as of such date, (2) no shares of Preferred Stock were issued and outstanding and (3) there were 1,375,723 shares of Capital Stock held by the Company as treasury shares. As of the
close of business on the Capitalization Date, with respect to the Plans, (x) there were outstanding Options 

  
 6 

 
to purchase or otherwise acquire (I) 485,630 shares of Common Stock, of which 443,050 were exercisable or vested as of such date and (II) there were outstanding Restricted Stock Units
covering 6,488,392 shares of Common Stock (including performance based Restricted Stock Units). As of the close of business on the Capitalization Date, there were 14,917,846 shares of Common Stock reserved for issuance pursuant to the convertible
debentures disclosed in the Company’s Form 10-K (“Convertible Debentures”) and 19,808,441 shares of Common Stock reserved for issuance pursuant to warrants. All outstanding shares of Common Stock have been duly
authorized and validly issued and are fully paid, nonassessable and free of any preemptive rights. 
 (ii) The Company has
reserved 11,148,871 shares of Common Stock under Plans. 
 (iii) Except as set forth in clauses (i) and (ii) above or
on Schedule 3.1(e)(iii), as of the close of business on the Capitalization Date, there are (A) no outstanding shares of capital stock of, or other equity or voting interest in, the Company, (B) no outstanding securities issued by
the Company that are convertible into or exchangeable for shares of capital stock of, or other equity or voting interest in, the Company, (C) no outstanding options, warrants, rights or other commitments or agreements to acquire from the
Company, or that obligates the Company to issue, any capital stock of, or other equity or voting interest in, or any securities convertible into or exchangeable for shares of capital stock of, or other equity or voting interest in, the Company,
(D) no obligations of the Company to grant, extend or enter into any subscription, warrant, right, convertible or exchangeable security or other similar agreement or commitment relating to any capital stock of, or other equity or voting
interest (including any voting debt) in, the Company (the items in clauses (A), (B), (C) and (D), together with the capital stock of the Company, being referred to collectively as “Company Securities”) and (E) no
other obligations of the Company or any of its Subsidiaries or Solar SPEs to make any payments based on the price or value of any Company Securities. There are no outstanding agreements of any kind which obligate the Company or any of its
Subsidiaries or Solar SPEs to repurchase, redeem or otherwise acquire any Company Securities. 
 (f) Acknowledgment Regarding
Purchase of Common Shares. The Company acknowledges and agrees that for purposes of Section 2.2(a)(iii) of the Affiliation Agreement, and the related exceptions to the Investor’s standstill obligations contained in the Affiliation
Agreement, the issuance of the Common Shares to the Investor is the issuance of “Exempt Excess Shares” to “Terra” (as such terms are defined in the Affiliation Agreement) in connection with the acquisition by the Company of
Tenesol. 
 (g) No General Solicitation. Neither the Company, nor any of its affiliates, nor any Person acting on its or
their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale of the Common Shares. 

(h) No Integrated Offering under Securities Act. Assuming the accuracy of the Investor’s representations and warranties set
forth in Section 3.2 hereof, none of the Company, any of its affiliates, and any Person acting on their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under
circumstances that would require registration of the issuance of any of the Common Shares under the Securities Act, whether through integration with prior offerings or otherwise. None of the Company, its affiliates and any Person acting on their
behalf will take any action or steps referred to in the preceding sentence that would require registration of the issuance of any of the Common Shares under the Securities Act. 

(i) Application of Takeover Protections; Rights Agreement. The Company and its board of directors have taken all necessary action,
if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under The Rights Agreement) or other similar anti-takeover provision under the Company’s certificate of
incorporation or the laws of the State of Delaware which is or could become applicable to the Investor as a result of the transactions contemplated by this Agreement, including, without limitation, the Company’s issuance of the Common Shares
and the Issuer’s ownership of the Common Shares. The Rights Plan has not been amended, rescinded or modified since the date it was entered into. The resolutions set forth on Schedule D of the Affiliation Agreement have not been amended,
rescinded or modified 

  
 7 

 
since their adoption, and no further action is necessary in connection with the issuance of the Common Shares to waive the implications of Section 203 of the DGCL to Parent, Terra, any Terra
Controlled Corporation and any Transferee (as such terms are defined in the Affiliation Agreement). 
 (j) SEC Documents;
Financial Statements. Since January 1, 2011 (the “Reporting Period”), the Company has timely filed all reports, schedules, forms, statements and other documents required to be filed by it with the SEC pursuant to the
reporting requirements of the Exchange Act (all of the foregoing filed during the Reporting Period or prior to the date of the Closing and all exhibits included therein and financial statements, notes and schedules thereto and documents incorporated
by reference therein being hereinafter referred to as the “SEC Documents”). The Company has delivered or made available to the Investor or their respective representatives true, correct and complete copies of the SEC Documents to
the extent such documents are not available on the EDGAR system, if any, and that have been requested by the Investor. As of their respective filing dates (or, if amended or superseded by a filing prior to the date of this Agreement, on the date of
such amended or superseded filing), the SEC Documents complied in all material respects with the requirements of the Exchange Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC
Documents, at the time they were filed with the SEC (or, if amended or superseded by a filing prior to the date of this Agreement, on the date of such amended or superseded filing), contained any untrue statement of a material fact or omitted to
state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. As of their respective filing dates (or, if amended or superseded
by a filing prior to the date of this Agreement, on the date of such amended or superseded filing), the financial statements of the Company included in the SEC Documents complied as to form in all material respects with applicable accounting
requirements and the published rules and regulations of the SEC with respect thereto. Such financial statements have been prepared in accordance with generally accepted accounting principles, consistently applied, during the periods involved (except
(i) as may be otherwise indicated in such financial statements or the notes thereto, or (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly
present in all material respects the financial position of the Company as of the dates thereof and the results of its operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit
adjustments). No other information provided by or on behalf of the Company to the Investor which is not included in the SEC Documents or in any disclosure schedules, contains any untrue statement of a material fact or omits to state any material
fact necessary in order to make the statements therein, in the light of the circumstance under which they are or were made not misleading. 
 (k) Absence of Certain Changes. Since October 3, 2011 there has been no Material Adverse Effect on the Company. The Company has not taken any steps to seek protection pursuant to any
bankruptcy law nor does the Company have any knowledge or reason to believe that its creditors intend to initiate involuntary bankruptcy proceedings or any actual knowledge of any fact that would reasonably lead a creditor to do so. The Company is
not as of the date hereof, and after giving effect to the transactions contemplated hereby to occur at the Closing, will not be Insolvent (as defined below). For purposes of this Section 3.1(k), “Insolvent” means, with respect to any
Person, (i) the present fair saleable value of such Person’s assets is less than the amount required to pay such Person’s total Indebtedness, (ii) such Person is unable to pay its debts and liabilities, subordinated, contingent
or otherwise, as such debts and liabilities become absolute and matured, (iii) such Person intends to incur or believes that it will incur debts that would be beyond its ability to pay as such debts mature or (iv) such Person has
unreasonably small capital with which to conduct the business in which it is engaged as such business is now conducted and is currently proposed to be conducted. 
 (l) Conduct of Business; Regulatory Permits. The Company is not in material violation of any term of or in default under its certificate of incorporation, any certificate of designations of any
outstanding series of preferred stock of the Company or its bylaws. The Company is not in violation of any judgment, decree or order or any statute, ordinance, rule or regulation applicable to the Company, and the Company will not conduct its
business in violation of any of the foregoing, except for possible violations which would not, individually or in 

  
 8 

 
the aggregate, reasonably be expected to have a Material Adverse Effect. The Company is not in material violation of any of the rules, regulations or requirements of the Principal Market and has
no knowledge of any facts or circumstances that would reasonably lead to delisting of the Common Stock by the Principal Market in the foreseeable future. Since October 3, 2011, (i) the Common Stock has been designated for quotation or
included for listing on the Principal Market, (ii) trading in the Common Stock has not been suspended by the SEC or the Principal Market and (iii) the Company has received no communication, written or oral, from the SEC or the Principal
Market regarding the suspension or delisting of the Common Stock from the Principal Market. The Company possess all certificates, authorizations and permits issued by the appropriate regulatory authorities necessary to its business, except where the
failure to possess such certificates, authorizations or permits could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, and the Company has not received any notice of proceedings relating to the
revocation or modification of any such certificate, authorization or permit. 
 (m) Principal Market Approval. The
Company has obtained or will obtain all required shareholder approvals under the rules, regularities or requirements of the Principal Market with respect to the issuance and sale of the Common Shares to the Investor prior to the Closing Date.

 (n) Foreign Corrupt Practices. Neither the Company nor any of its Subsidiaries nor any director or officer, nor to the
Company’s knowledge, any agent, employee or other Person acting on behalf of the Company has, in the course of its actions for, or on behalf of, the Company (i) used any corporate funds for any unlawful contribution, gift, entertainment or
other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation in any material
respect of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government official or
employee. 
 (o) Sarbanes-Oxley Act. The Company is in material compliance with any and all applicable requirements of
the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the SEC thereunder that are effective as of the date hereof. 

(p) Insurance. The Company is insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as management of the Company believes to be prudent and customary in the businesses in which the Company is engaged. The Company has not been refused any insurance coverage sought or applied for and the Company does not have any reason to
believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would, individually or in the
aggregate, not have a Material Adverse Effect. 
 (q) Employee Relations. 

(i) Except as disclosed in the SEC Documents, no executive officer of the Company is in violation of any material term of any employment
contract, confidentiality, disclosure or proprietary information agreement, non-competition agreement, or any other contract or agreement or any restrictive covenant, and the continued employment of each such executive officer does not subject the
Company to any liability with respect to any of the foregoing matters. 
 (ii) The Company, to its knowledge, is in compliance
with all federal, state, local and foreign laws and regulations respecting labor, employment and employment practices and benefits, terms and conditions of employment and wages and hours, except where failure to be in compliance would not,
individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect. 
 (r) Title. The
Company has good and marketable title in fee simple to all real property and good and marketable title to all personal property owned by them which is material to the business of the Company, in

  
 9 

 
each case free and clear of all liens, encumbrances and defects except such as do not materially affect the value of such property and do not interfere with the use made and proposed to be made
of such property by the Company. Any real property and facilities held under lease by the Company are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and
proposed to be made of such property and buildings by the Company. 
 (s) Intellectual Property Rights. The Company owns
or possesses adequate rights or licenses to use or could obtain on commercially reasonable terms all trademarks, service marks and all applications and registrations therefor, trade names, patents, patent rights, copyrights, original works of
authorship, inventions, trade secrets and other intellectual property rights (“Intellectual Property Rights”) necessary to conduct its business as conducted on the date of this Agreement, except for such Intellectual Property
Rights, the inability to use would not, individually or in the aggregate, have a Material Adverse Effect. To the knowledge of the Company, no product or service of the Company infringes the Intellectual Property Rights of others which would
reasonably be expected to result, individually or in the aggregate, in a Material Adverse Effect. There is no claim, action or proceeding being made or brought, or to the knowledge of the Company, being threatened, against the Company regarding
(i) its Intellectual Property Rights, or (ii) that the products or services of the Company infringe the Intellectual Property Rights of others. The Company has taken reasonable security measures to protect the secrecy, confidentiality and
value of all of its Intellectual Property Rights. 
 (t) Environmental Laws. The Company (i) is in compliance with
any and all Environmental Laws (as hereinafter defined), (ii) has received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct its business and (iii) is in compliance with all terms and
conditions of any such permit, license or approval where, in each of the foregoing clauses (i), (ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect. The term
“Environmental Laws” means all federal, state, local or foreign laws relating to pollution or protection of human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface or
subsurface strata), including, without limitation, laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous
Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands or
demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations issued, entered, promulgated or approved thereunder. 
 (u) Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to have a Material Adverse Effect, the Company (i) has made or filed all
foreign, federal and state income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown
or determined to be due on such returns, reports and declarations, except those being contested in good faith and (iii) has set aside on its books provision reasonably adequate for the payment of all taxes for periods subsequent to the periods
to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company know of no basis for any such claim. 

(v) Internal Accounting and Disclosure Controls. Except as described in the SEC Documents, the Company maintains a system of
internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with generally accepted accounting principles and to maintain asset and liability accountability, (iii) access to assets or incurrence of liabilities is permitted only in accordance with
management’s general or specific authorization and (iv) the recorded accountability for assets and liabilities is compared with the existing assets and liabilities at reasonable intervals and appropriate action is taken with respect to any
difference. Except as disclosed in the SEC Documents, the Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-14 

  
 10 

 
under the Exchange Act) that are effective in ensuring that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the
Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the SEC including, without limitation, controls and procedures designed in to ensure that information required to be disclosed
by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive officer or officers and its principal financial officer or officers, as
appropriate, to allow timely decisions regarding required disclosure. 
 (w) Off Balance Sheet Arrangements. There is no
transaction, arrangement, or other relationship between the Company and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise would be
reasonably likely to, individually or in the aggregate, have a Material Adverse Effect. 
 (x) Investment Company Status.
The Company is not, and upon consummation of the sale of the Common Shares will not be, an “investment company,” a company controlled by an “investment company” or an “affiliated person” of, or “promoter” or
“principal underwriter” for, an “investment company” as such terms are defined in the Investment Company Act of 1940, as amended. 
 (y) Form S-3 Eligibility. The Company is eligible to register the Common Shares for resale by the Investor using Form S-3 promulgated under the Securities Act in accordance with the provisions of
the Registration Rights Agreement. 
 (z) Manipulation of Price. The Company has not, and to its knowledge (assuming the
accuracy of the Investor’s representations and warranties set forth in Section 3.2 hereof) no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or
manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Common Shares, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Common Shares, or
(iii) paid or agreed to pay to any person any compensation for soliciting another to purchase any other securities of the Company. 
 3.2 Representations and Warranties of Investor. Investor hereby represents and warrants to the Company as follows: 
 (a) Organization; Authority. Investor is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization with the requisite corporate,
partnership or other power and authority to enter into the Transaction Documents to which it is a party and to consummate the Transactions and otherwise to carry out its obligations hereunder and thereunder. The purchase by Investor of the Common
Shares hereunder and the consummation of the Transactions have been duly authorized by all necessary corporate, partnership or other action on the part of Investor. This Agreement and the Transaction Documents to which Investor is a party or has or
will execute have been duly executed and delivered by Investor and constitutes the valid and binding obligation of Investor, enforceable against it in accordance with its terms, except (i) as limited by general equitable principles and
applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law. 
 (b) No Public Sale or Distribution. Investor is acquiring the Common Shares for its own account and not with a view towards, or for resale in connection with, the public sale or distribution
thereof, except pursuant to sales registered under the Securities Act or under an exemption from such registration and in compliance with applicable federal and state securities laws, and Investor does not have a present arrangement to effect any
distribution of the Common Shares to or through any person or entity. 
 (c) Investor Status. Investor is an
“accredited investor” as defined in Rule 501(a) under the Securities Act or a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act. Investor is not a

  
 11 

 
registered broker dealer registered under Section 15(a) of the Exchange Act, or a member of the Financial Industry Regulatory Authority, Inc. (“FINRA”) or an entity
engaged in the business of being a broker dealer. Investor is not affiliated with any broker dealer registered under Section 15(a) of the Exchange Act, or a member of the FINRA or an entity engaged in the business of being a broker dealer.
Investor is a resident of the following jurisdiction: France. 
 (d) General Solicitation. Investor is not purchasing the
Common Shares as a result of any advertisement, article, notice or other communication regarding the Common Shares published in any newspaper, magazine or similar media, broadcast over television or radio, disseminated over the Internet or presented
at any seminar or any other general solicitation or general advertisement. 
 (e) Experience of Investor. Investor,
either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Common Shares, and has
so evaluated the merits and risks of such investment. Investor understands that it must bear the economic risk of this investment in the Common Shares indefinitely, and is able to bear such risk and is able to afford a complete loss of such
investment. 
 (f) Access to Information. Investor acknowledges that it has been afforded: (i) the opportunity to
ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Common Shares and the merits and risks of investing in the Common Shares;
(ii) access to information (other than material non-public information) about the Company and each Subsidiary and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate
its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the
investment. Investor acknowledges receipt of copies of the SEC Reports. 
 (g) No Governmental Review. Such Investor
understands that no United States federal or state agency or any other government or governmental agency has passed on or made any recommendation or endorsement of the Common Shares or the fairness or suitability of the investment in the Common
Shares nor have such authorities passed upon or endorsed the merits of the offering of the Common Shares. 
 (h) No
Conflicts. The execution, delivery and performance by Investor of this Agreement and the consummation by Investor of the transactions contemplated hereby will not (i) result in a violation of the organizational documents of Investor or
(ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture
or instrument to which Investor is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws) applicable to Investor, except in the case of clauses (ii) and
(iii) above, for such that would not result in a Material Adverse Effect and do not otherwise affect the ability of such Investor to consummate the transactions contemplated hereby or perform its obligations hereunder. 

(i) Reliance on Exemptions. Investor understands that the Common Shares are being offered and sold to it in reliance on specific
exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and Investor’s compliance with, the representations, warranties,
agreements, acknowledgments and understandings of Investor set forth herein and in the other Transaction Documents in order to determine the availability of such exemptions and the eligibility of Investor to acquire the Common Shares. 

(j) Transfer or Resale. Investor understands that: (i) the Common Shares have not been and are not being registered under the
Securities Act or any state securities laws, and may not be offered for sale, sold, assigned or transferred unless (A) subsequently registered thereunder, (B) Investor shall have delivered to the

  
 12 

 
Company an opinion of counsel, in a form reasonably acceptable to the Company, to the effect that such Common Shares to be sold, assigned or transferred may be sold, assigned or transferred
pursuant to an exemption from such registration, or (C) Investor provides the Company with reasonable assurance that such Common Shares can be sold, assigned or transferred pursuant to Rule 144 promulgated under the Securities Act (or a
successor rule thereto); (ii) any sale of the Common Shares made in reliance on Rule 144 may be made only in accordance with the terms of Rule 144 and further, if Rule 144 is not applicable, any resale of the Common Shares under
circumstances in which the seller (or the Person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the Securities Act) may require compliance with some other exemption under the Securities Act or the rules
and regulations of the SEC thereunder; and (iii) except as set forth in the Registration Rights Agreement, neither the Company nor any other Person is under any obligation to register the Common Shares under the Securities Act or any state
securities laws or to comply with the terms and conditions of any exemption thereunder. 
 (k) Restrictions. Investor
understands and agrees that the book entry representing the Common Shares shall initially be restricted as required by the “blue sky” laws of any state. Investor understands that such book entry restrictions shall be removed and the
Company shall issue a certificate without legend to the holder of the Common Shares, or establish and credit a Direct Registration System entry representing the Common Shares to a segregated account established by the Transfer Agent for the
Investor’s benefit, or issue to such holder by electronic delivery at the applicable balance account at The Depository Trust Company (“DTC”), if, unless otherwise required by state securities laws, (i) such Common
Shares are registered for resale under the Securities Act, (ii) in connection with a sale, assignment or other transfer, such holder provides the Company with an opinion of a law firm reasonably acceptable to the Company, in a form reasonably
acceptable to the Company, to the effect that such sale, assignment or transfer of the Common Shares may be made without registration under the applicable requirements of the Securities Act, (iii) such holder provides the Company with
reasonable assurance that the Common Shares can be sold, assigned or transferred pursuant to Rule 144, or (iv) otherwise provided in the Transfer Agent Instructions. 
 (l) Manipulation of Price. Investor has not, and to its knowledge (assuming the accuracy of the Company’s representations and warranties set forth in Section 3.1 hereof) no one acting on
its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Common Shares,
(ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Common Shares, or (iii) paid or agreed to pay to any person any compensation for soliciting another to purchase any other securities of the
Company. 
 ARTICLE IV 
 OTHER AGREEMENTS OF THE PARTIES 
 4.1 Transfer Restrictions.

 (a) Investor covenants that the Common Shares will only be disposed of pursuant to an effective registration statement under,
and in compliance with the requirements of, the Securities Act or pursuant to an available exemption from the registration requirements of the Securities Act, and in compliance with any applicable state securities laws. In connection with any
transfer of Common Shares other than pursuant to an effective registration statement or to the Company, or any transfer of Common Shares pursuant to Rule 144, the Company may require the transferor to provide to the Company an opinion of
counsel selected by the transferor, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration under the Securities Act. 

(b) Investor agrees that the book entry evidencing any of the Common Shares shall initially be restricted. 

  
 13 

 Certificates evidencing the Common Shares shall not be required to contain any restrictive legend, and the
book entry evidencing the Common Shares shall not be required to be restricted (i) while a registration statement covering the resale of the Common Shares is effective under the Securities Act, (ii) following any sale of such Common Shares
pursuant to Rule 144 if the holder provides the Company with a legal opinion (and the documents upon which the legal opinion is based) reasonably acceptable to the Company to the effect that the Common Shares can be sold under Rule 144,
(iii) if the Common Shares are eligible for sale under Rule 144, or (iv) if the holder provides the Company with a legal opinion (and the documents upon which the legal opinion is based) reasonably acceptable to the Company to the
effect that a legend or book entry restriction is not required under applicable requirements of the Securities Act (including controlling judicial interpretations and pronouncements issued by the Staff of the SEC). The Company covenants and agrees
that restrictive legends and book entry restrictions shall be removed and the Company shall issue a certificate without legend to the holder of the Common Shares or establish and credit a Direct Registration System entry representing the Common
Shares to a segregated account established by the Transfer Agent for the Investor’s benefit, or issue to such holder by electronic delivery at the applicable balance account at DTC, if, unless otherwise required by state securities laws,
(w) it is so provided in the Transfer Agent Instructions, (x) such Common Shares are registered for resale under the Securities Act, (y) in connection with a sale, assignment or other transfer, such holder provides the Company with an
opinion of a law firm reasonably acceptable to the Company, in a form reasonably acceptable to the Company, to the effect that such sale, assignment or transfer of the Common Shares may be made without registration under the applicable requirements
of the Securities Act, or (z) such holder provides the Company with reasonable assurance that the Common Shares can be sold, assigned or transferred pursuant to Rule 144. 

4.2 Furnishing of Information. Until the date that the Investor owning Common Shares has sold the Common Shares, the
Company covenants to use its best efforts to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act.

 4.3 Integration. The Company shall not, and shall use its best efforts to ensure that no Affiliate thereof
shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Common Shares in a manner that would
require the registration under the Securities Act of the sale of the Common Shares to Investor or that would be integrated with the offer or sale of the Common Shares for purposes of the rules and regulations of any Trading Market. 

4.4 Securities Laws Disclosure; Publicity. The Company shall timely file any filings and notices required by the SEC or
applicable law with respect to the transactions contemplated hereby. 
 4.5 Use of Proceeds. The Company intends
to use the net proceeds from the sale of the Common Shares to for general corporate purposes, including working capital, the retirement of outstanding debt or for potential acquisitions. Pending these uses, the Company intends to invest the net
proceeds from this offering in short-term, interest-bearing, investment-grade securities, or as otherwise pursuant to the Company’s customary investment policies. 
 4.6 Form D and Blue Sky. The Company agrees to file a Form D with respect to the Common Shares as required under Regulation D and to provide a copy thereof to each Buyer promptly after such
filing. The Company, on or before the Closing Date, shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for or to qualify the Common Shares for sale to the Investor at the Closing pursuant to
this Agreement under applicable securities or “Blue Sky” laws of the states of the United States (or to obtain an exemption from such qualification), and shall provide evidence of any such action so taken to the Investor on or prior to the
Closing Date. The Company shall make all filings and reports relating to the offer and sale of the Common Shares required under applicable securities or “Blue Sky” laws of the states of the United States following the Closing Date.

  
 14 

 4.7 Listing. The Company shall promptly secure the listing of all of the
Common Shares, once they have been issued, upon each national securities exchange and automated quotation system, if any, upon which shares of Common Stock are then listed (subject to official notice of issuance) and shall maintain, so long as any
other shares of Common Stock shall be so listed, such listing of all Common Shares from time to time issuable under the terms of the Transaction Documents. The Company shall maintain the Common Stock’s authorization for quotation on the
Principal Market. The Company shall not take any action which would be reasonably expected to result in the delisting or suspension of the Common Stock on the Principal Market. 
 ARTICLE V 
 CONDITIONS 

5.1 Conditions Precedent to the Obligations of Investor. The obligation of Investor to acquire the Common Shares at the
Closing is subject to the satisfaction or waiver by Investor, at or before the Closing, of each of the following conditions: 

(a) Representations and Warranties. The representations and warranties of the Company contained herein shall be true and correct in
all material respects as of the date when made and as of the Closing as though made on and as of such date (except for those representations and warranties that are (1) already qualified by materiality or (2) speak as of a specific date,
which shall be true and correct as of such specified date). 
 (b) Performance. The Company shall have performed,
satisfied and complied in with all covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or prior to the Closing. 

(c) Absence of Litigation. No action, suit or proceeding by or before any court or any governmental body or authority, against the
Company or any Subsidiary pertaining to the transactions contemplated by this Agreement or their consummation, shall have been instituted on or before the Closing Date. 
 (d) Board Approval. The terms and conditions of the issuance of the Common Shares and the Transaction Documents shall have been approved by a majority of the disinterested directors of the Board.

 (e) Approvals. The Company shall have obtained all governmental, regulatory or third party consents and approvals, if
any, necessary for the sale of the Common Shares, including, without limitation, from its Principal Market. In addition, the Company shall have provided to each stockholder of the Company entitled to vote on such matters under Delaware Corporate Law
a copy of an information statement or proxy statement, substantially in the form which has been previously reviewed by the Investor and counsel for Investor, soliciting such stockholder’s written consent for approval of resolutions providing
for the Company’s issuance of all of the Common Shares as described in the Transaction Documents in accordance with applicable Delaware law, U.S. federal securities law, the rules and regulations of the Principal Market and any other applicable
law, and have obtained prior to the Closing Date of this Agreement the required written consents approving the issuance of all of the Common Shares as described in the Transaction Documents. 

(f) Tenesol Acquisition. The closing of the Tenesol Acquisition shall have occurred, or shall occur concurrently with the Closing
hereunder. 
 (g) Deliverables. The Company shall have executed each of the Transaction Documents to which it is a party
and delivered the same to Investor. The Company shall have delivered to Investor those items required by Section 2.2(a). 

  
 15 

 5.2 Conditions Precedent to the Obligations of the Company. The obligation of
the Company to sell the Common Shares at the Closing is subject to the satisfaction or waiver by the Company, at or before the Closing, of each of the following conditions: 
 (a) Representations and Warranties. The representations and warranties of Investor contained herein shall be true and correct in all material respects as of the date when made and as of the Closing
Date as though made on and as of such date (except for those representations and warranties that speak as of a specific date, which shall be true and correct as of such specified date). 

(b) Performance. Investor shall have performed, satisfied and complied with all covenants, agreements and conditions required by
the Transaction Documents to be performed, satisfied or complied with by Investor at or prior to the Closing. 
 (c)
Deliverables. Investor shall have executed each of the Transaction Documents to which it is a party and delivered the same to the Company. Investor shall have delivered to the Company those items required by Section 2.2(b).

 ARTICLE VI 
 MISCELLANEOUS 
 6.1 Termination. This Agreement may be
terminated by the Company by written notice to Investor, if the Closing has not been consummated by March 30, 2012; provided that no such termination will affect the right of any party to sue for any breach by the other party (or parties).

 6.2 Fees and Expenses. Except as expressly set forth in the Transaction Documents to the contrary, each party
shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The
Company shall pay all Transfer Agent fees, stamp taxes and other taxes and duties levied in connection with the sale and issuance of the applicable Common Shares. 
 6.3 Entire Agreement. The Transaction Documents, together with the Exhibits, Annexes and Schedules thereto, contain the entire understanding of the parties with respect to the subject matter
hereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules. At or after the Closing, and without further
consideration, the Company and Investor will execute and deliver to Investor such further documents as may be reasonably requested in order to give practical effect to the intention of the parties under the Transaction Documents. 

6.4 Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission and electronic or mechanical confirmation of receipt, if such notice or communication is delivered via facsimile or email at the facsimile
number or email address specified in this Section prior to 12:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission and electronic or mechanical confirmation of receipt, if such notice or
communication is delivered via facsimile or email at the facsimile number or email address specified in this Section on a day that is not a Trading Day or later than 12:30 p.m. (New York City time) on any Trading Day, (c) the Trading Day
following the date of deposit with a nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required to be given. The addresses, facsimile numbers and email addresses for such notices and
communications are those set forth on the signature pages hereof, or such other address or facsimile number as may be designated in writing hereafter, in the same manner, by any such Person. 

6.5 Amendments; Waivers. No provision of this Agreement may be waived or amended except in a written instrument signed, in
the case of an amendment, by the Company and Investor or, in the case of a waiver, by the 

  
 16 

 
party against whom enforcement of any such waiver is sought. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing
waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any
such right. 
 6.6 Construction. The headings herein are for convenience only, do not constitute a part of this
Agreement and shall not be deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will
be applied against any party. 
 6.7 Successors and Assigns. This Agreement shall be binding upon and inure to the
benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of Investor; provided, however this Agreement shall
be assigned to any corporation or association into which the Company may be merged or converted or with which it may be consolidated, or any corporation, association or other similar entity resulting from any merger, conversion or consolidation to
which the Company shall be a party without the execution or filing of any paper with any partner hereto or any further act on the part of any of the parties to this Agreement except where an instrument of transfer or assignment is required by law to
effect such succession, anything herein to the contrary notwithstanding. Investor may not assign this Agreement or any rights or obligations hereunder to any transferee of Investor that is a Total G&P Controlled Corporation (as defined in the
Affiliation Agreement). 
 6.8 No Third-Party Beneficiaries. This Agreement is intended for the benefit of the
parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person. 
 6.9 Governing Law; Venue; Waiver of Jury Trial. 
 This Agreement
shall be governed by and construed in accordance with the laws of the State of New York, regardless of the laws that might otherwise govern pursuant to applicable principles of conflicts of law thereof. 

Each of the parties hereto irrevocably consents to the exclusive jurisdiction and venue in any state court within the State of New York
(or, if a state court located within the State of New York declines to accept jurisdiction over a particular matter, any court of the United States located in the State of New York) in connection with any matter based upon or arising out of this
Agreement or the transactions contemplated hereby and agrees that process may be served upon such party in any manner authorized by the laws of the State of New York or in such other manner as may be lawful, and that service in such manner shall
constitute valid and sufficient service of process. Each party hereto waives and covenants not to assert or plead any objection that such party might otherwise have to such jurisdiction, venue and process. Each party hereto hereby agrees not to
commence any legal proceedings relating to or arising out of this Agreement or the transactions contemplated hereby in any jurisdiction or courts other than as provided herein. 

EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED
ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF A PARTY IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT HEREOF. 
 6.10 Survival. With the exception of the representations and warranties set forth in Sections 3.1(a), (b), (c), (d), (e) and (f), which shall survive indefinitely, the representations
and warranties contained herein shall not survive the Closing Date. 

  
 17 

 6.11 Execution. This Agreement may be executed in two or more counterparts,
all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the
same counterpart. In the event that any signature is delivered by facsimile transmission or email attachment, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the
same force and effect as if such facsimile or email-attached signature page were an original thereof. 
 6.12
Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired
thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Agreement. 

6.13 Replacement of Common Shares. If any certificate or instrument evidencing any Common Shares is mutilated, lost, stolen
or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of such loss, theft or destruction and the execution by the holder thereof of a customary lost certificate affidavit of that fact and an agreement to indemnify and hold harmless the Company for any losses in connection
therewith. The applicants for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs associated with the issuance of such replacement Common Shares. 

6.14 Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery
of damages, Investor and the Company will be entitled to seek specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations
described in the foregoing sentence and hereby agree to waive in any action for specific performance of any such obligation (other than in connection with any action for a temporary restraining order) the defense that a remedy at law would be
adequate. 
 [SIGNATURE PAGES TO FOLLOW] 

  
 18 

 IN WITNESS WHEREOF, the parties hereto have caused this Private Placement Agreement to be
duly executed by their respective authorized signatories as of the date first indicated above. 
  

			
	COMPANY
	
	SUNPOWER CORPORATION
		
	By:	 	/s/ Thomas H. Werner
		 	Name: Thomas H. Werner
		 	Title: Chief Executive Officer

 

	
	 77 Rio Robles Street
 San Jose,
CA 95134
 Attention: Chief Financial Officer
 Telephone: 408-240-5500
 Facsimile: 408-240-5404

	
	With a copy to:
	
	 SunPower Corporation
 77 Rio
Robles Street
 San Jose, CA 95134

Attention: Navneet Govil, Vice President and Treasurer
 Telephone: 408-457-2655
 E-mail: navneet.govil@sunpowercorp.com

	
	With a copy to:
	
	 SunPower Corporation
 1414
Harbour Way South
 Richmond, CA 94804

Attention: General Counsel
 Telephone:
510-540-0550
 Facsimile: 510-540-0552

	
	With a copy to:
	
	Jones Day
	1755 Embarcadero Road
	Palo Alto, CA 94303
	Facsimile No.: (650) 739-3900
	Telephone No.: (650) 739-3999
	Attn: R. Todd Johnson

 
			
	INVESTOR
	
	TOTAL GAS & POWER USA, SAS
		
	By:	 	/s/ Arnaud Chaperon
		 	Name: Arnaud Chaperon
		 	Title: President

  

	
	 Total Gas & Power USA, SAS
 2, place Jean Millier
 La Défense 6
 92400 Courbevoie
 France
 Attention: Arnaud Chaperon, President
 Facsimile: +33 1 47 44 27 90

 
 with copies (which shall not constitute notice) to:

	
	 Total S.A.
 2, place Jean
Millier
 La Défense 6
 92400
Courbevoie
 France
 Attention: Humbert
de Wendel, Senior Vice President Corporate Business Development
 Facsimile: +33 1 47 44 50 95

	
	 Total S.A.
 2, place Jean
Millier
 La Défense 6
 92400
Courbevoie
 France
 Attention: Jonathan
Mars, Vice President, Legal Director Mergers, Acquisitions & Finance
 Facsimile: +33 1 47 44 43 05

	
	With a copy (which shall not constitute notice) to:
	
	 Wilson Sonsini Goodrich & Rosati
 Professional Corporation
 650 Page Mill Road

Palo Alto, CA 94304
 Attn: David Segre

Attn: Richard Cameron Blake
 Attn: Michael
Occhiolini
 Telephone: (650) 493-9300
 Facsimile: (650) 493-6811

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}]]